October 2025
1. PARSYAN A, Athwal H, Bhat V, Allan AL, et al
   Polo-like Kinase 4 (PLK4) as a Therapeutic Target in Breast Cancer.
   Carcinogenesis. 2025 Oct 14:bgaf067. doi: 10.1093.
   

   >> Share

   
   September 2025
2. 
   Correction to: p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis.
   Carcinogenesis. 2025;46:bgaf042.
   

   >> Share

   
   
3. YADAV R, Goel S, Kumari L, Dahiya D, et al
   Expression profile of Claudins 3, 4, and 7 in breast tumors and its correlation with clinicopathological features.
   Carcinogenesis. 2025;46:bgaf049.
   

   >> Share

   
   
4. JEYAKUMAR E, Sundararaju S, Annett S, Elrayess MA, et al
   Mammary Adipose Dysfunction in the Dual Epidemic of Obesity and Breast Cancer.
   Carcinogenesis. 2025 Sep 3:bgaf053. doi: 10.1093.
   

   >> Share

   
   August 2025
5. WANG J, Wang D, Zhang X, Xu X, et al
   HECTD3 E3 ligase mediates ubiquitination of AKT-phosphorylated CMTM3 in HER2-overexpressed breast cancer cells.
   Carcinogenesis. 2025 Aug 21:bgaf048. doi: 10.1093.
   

   >> Share

   
   April 2025
6. GODINA C, Rosendahl AH, Goncalves de Oliveira K, Khazaei S, et al
   Genetic determinants and clinical significance of circulating and tumor-specific levels of insulin-like growth factor binding protein 7 (IGFBP7) in a Swedish breast cancer cohort.
   Carcinogenesis. 2025 Apr 15:bgaf020. doi: 10.1093.
   

   >> Share

   
   
7. ZHANG Y, Li Q, Lan J, Xie G, et al
   Triple-negative breast cancer molecular subtypes and potential detection targets for biological therapy indications.
   Carcinogenesis. 2025;46:bgaf006.
   

   >> Share

   
   
8. PENG C, Liu Y, Heng YJ, Bodelon C, et al
   The impact of reproductive factors on breast tumor and normal-adjacent tissue immune profile from menarche to menopause.
   Carcinogenesis. 2025;46:bgaf028.
   

   >> Share

   
   January 2025
9. ZHU Y, Song Y, Zhou X, Zhang W, et al
   Antibody-Drug Conjugates in breast cancer.
   Carcinogenesis. 2025 Jan 1:bgae082. doi: 10.1093.
   

   >> Share

   
   March 2024
10. KIM H, Son S, Ko Y, Lim H, et al
    CYR61 confers chemoresistance by upregulating survivin expression in triple-negative breast cancer.
    Carcinogenesis. 2024 Mar 6:bgae013. doi: 10.1093.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share